Lithia & Driveway (NYSE: LAD), largest global automotive retailer, today reported financial results for the fourth quarter and full year 2025.

MALTA, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the fourth quarter and fiscal year ended December 31, 2025.

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of three abstracts for presentation at the 2026 ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the fourth quarter and full year ended ...

Palo Alto Networks held its Ignite on Tour London 2026 event recently and an element of the organisation’s presentations mentioned the now-released Global Incident Report 2026.

Select Water Solutions, Inc. (NYSE: WTTR) ("Select," the "Company," "we," "our" or "us"), a leading provider of sustainable water infrastructure and chemical solutions, today announced its financial ...

Siili Solutions Plc, Financial statements bulletin, 1 January-31 December 2025 (unaudited) Siili Solutions Plc, Financial statements bulletin, 1 January-31 December 2025 (unaudited) ...

Hello, everyone, and thank you for your interest in BP's Fourth Quarter 2025 Results. I'm here with Kate Thompson, Chief Financial Officer. This video presents our full year and fourth quarter ...

Q4 2025 Earnings Call February 11, 2026 8:00 AM ESTCompany ParticipantsSean Moshier - Vice President of Investor ...

GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the fourth quarter and fiscal year ended December 31, 2025. Key ...

Siili Solutions Plc Stock Exchange Release 11 February 2026 at 8:30 a.m. (Finnish time) The shareholders of Siili Solutions Plc are invited to the Annual General Meeting to be held on Wednesday, 8 ...

PYRUKYND (mitapivat) worldwide net revenues of $20.0 million in fourth quarter and $54.0 million for full yearAQVESME (mitapivat) for thalassemia now available in U.S. following FDA approvalCompany wi ...